Phase 1/2 study of H3B-6545 in women with locally advanced/metastatic estrogen receptor-positive, HER2-negative breast cancer.

ABSTRACT:

SUBMITTER: Hamilton E 

PROVIDER: S-EPMC12363031 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature